# Lamellar Biomedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lamellar-biomedical

- Industry: Medical Devices & Equipment
- Headquarters: UK
- Website: www.lamellar.com
- Total disclosed funding: $13M
- Latest round: Series C (Mar 31, 2017)
- Investors on record: 5

## About

Lamellar Biomedical Ltd is a UK-based company focused on developing innovative biomedical solutions, leveraging advanced technologies to enhance therapeutic applications in various medical fields.Lamellar Biomedical Ltd specializes in biomedical solutions and was founded in 2007 in the UK. The company has undergone no significant pivots and operates independently. Founded by experienced individuals in the biotechnology sector, it has completed three deals since inception. In March 2017, the company raised GBP 5.75 million in a Series C round led by Invesco Asset Management, which also included Scottish Enterprise. This funding valued the company at approximately GBP 33.04 million post-money.Lamellar Biomedical Ltd focuses on providing advanced biomedical solutions designed to improve patient outcomes through innovative technologies. Their offerings include specialized therapies and applications aimed at enhancing health care delivery in multiple sectors. The company serves a diverse clientele, including healthcare institutions and research organizations, providing them with tailored solutions that address specific medical needs.In the most recent fiscal year of 2020, Lamellar Biomedical Ltd reported an EBITDA loss of GBP 2,319,770.4, reflecting the challenges in the biomedical sector even as it continues to develop and market its solutions.The company plans to leverage the GBP 5.75 million raised in its latest funding round in March 2017 to enhance its product development initiatives, targeting the introduction of new biomedical solutions aimed at expanding its service offerings. Lamellar Biomedical Ltd is also exploring opportunities to enter new markets in Europe and Asia, with a focus on solidifying its presence in these regions by 2023. The funding will support research and development efforts to drive these growth strategies.

## Funding rounds

- Series C, Mar 31, 2017, $7.2M — Invesco Asset Management, Scottish Enterprise
- Series A, Dec 6, 2012, $5.6M — East West Capital Partners, Invesco Asset Management, Barwell, Scottish Enterprise, TRICAPITAL

## Investors

- East West Capital Partners (https://capitalatlas.ai/funds/east-west-capital-partners) — Series A
- Invesco Asset Management — Series A, Series C
- Barwell (https://capitalatlas.ai/funds/barwell) — Series A
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Series A, Series C
- TRICAPITAL (https://capitalatlas.ai/funds/tricapital) — Series A